Almere, The Netherlands

July 23, 2019, 6 p.m. CET



ASM International N.V. (Euronext Amsterdam: ASM) today reports its second quarter 2019 operating results (unaudited) in accordance with IFRS.


EUR million

Q2 2018

Q1 2019

Q2 2019

New orders




Net sales




Gross profit margin %







Operating result




Result from investments (excluding amortization intangible assets resulting from the sale of ASMPT stake in 2013)




Amortization intangible assets (resulting from the sale of ASMPT stake in 2013)







Net earnings




Normalized net earnings (excluding amortization intangible assets resulting from the sale of ASMPT stake in 2013 and result from sale of ASMPT shares)




•    New orders were €373 million. Excluding €103 million related to the patent litigation settlement new orders were €270 million.

•     Net sales for the second quarter 2019 were €363 million. Excluding €103 million related to the patent litigation settlement, net sales were €260 million and increased 5% compared to the previous quarter.

•    Gross profit margin was 59.0% in Q2 2019 and 42.8% excluding the patent litigation settlement compared to 41.3% in the previous quarter.

•    Operating result increased to €150 million. Excluding the patent litigation settlement operating result was stable at €47 million compared to the previous quarter.

•    Normalized net earnings, including the patent litigation settlement, for the second quarter 2019 increased by €72 million compared to Q1 2019. Besides the positive impact of the patent litigation settlement net earnings in Q2 were negatively impacted by adverse currency effects and the increase in taxes due to the full utilization of the remaining net operating losses in the Netherlands. Results from investments decreased to €2 million.


Commenting on the results, Chuck del Prado, President and Chief Executive Officer of ASM International said:

"In Q2 we realized sales of €363 million. Excluding the €103 million related to the reported patent litigation settlement, the sales of €260 million showed a 25% sales increase year-on-year, reaching the highest level ever, driven by continuous high demand in the logic/foundry segment. Our order intake, at €373 million (€270 million excluding the patent litigation settlement) was again very strong. Sales as well as order intake were above our guidance of respectively €230-250 million and €240-260 million. The high order intake in Q2 was led by logic. Our cash position in the quarter increased substantially and still excludes the cash proceeds from the litigation settlement which will come in in the next quarters. Based on this we today announced the authorization of a new €100 million share buyback program."


For Q3, on a currency comparable level, we expect sales of €250-270 million while bookings, on a currency comparable level, are expected to also be in the range of €250-270 million. For 2019, general expectations are now that the wafer fab equipment (WFE) market will decline with a high teens percentage. While expectations for the memory-segment have further weakened, the healthy demand in the logic and foundry segments in the first half is expected to continue in the second half of 2019. Based upon this current market view, we maintain our expectation to meaningfully outperform the WFE market in 2019.


ASMI announced today that its Management Board authorized the repurchase of up to €100 million of the Company's common shares within the 2019-2020 time frame. This buyback program will be executed by intermediaries and will end as soon as the aggregate purchase price of the common shares acquired by ASMI has reached €100 million.

On May 20, 2019 the General Meeting of Shareholders authorized ASMI for a period of 18 months to acquire common shares up to 10% of its then issued capital.

The repurchase program is part of ASMI's commitment to use excess cash for the benefit of its shareholders.

ASMI further announces that the withdrawal of 5 million treasury shares has become effective as of July 23, 2019. As of that date, the number of issued shares is 51,297,394.

About ASM International

ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide production solutions for wafer processing (Front-end segment) as well as for assembly & packaging and surface mount technology (Back-end segment) through facilities in the United States, Europe, Japan and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASMI's website at

Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

ASM International will host an investor conference call and web cast on Wednesday, July 24, 2019 at 15:00 Continental European Time (9:00 a.m. - US Eastern Time).

The teleconference dial-in numbers are as follows:

  • United States:          +1 631 510 7495
  • International:            +44 (0) 844 571 8892 
  • The Netherlands:      +31 (0)20 714 3545
  • Access Code:          1164706

A simultaneous audio webcast and replay will be accessible at .


Investor contact:

Victor Bareño

T: +31 88 100 8500


Media contact:

Ian Bickerton

T: +31 625 018 512




About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Sista dag för handel med BTA B i Oboya6.12.2019 13:14:00 CETPressemelding

Oboya Horticulture Industries AB: s (” Oboya” eller” Bolaget”) företrädesemission har registrerats vid Bolagsverket. Sista dag för handel i Bolagets betalda tecknade aktier, OBOYA BTA B, är den 11 december 2019. Stoppdag hos Euroclear för växling från BTA till aktier är den 13 december 2019. De nya aktierna beräknas bokas ut på respektive aktieägares VP-konto/depå den 17 december 2019. Efter registrering av företrädesemissionen och den kvittningsemission som offentliggjordes den 25 november 2019 uppgår Oboyas aktiekapital till 1 256 175,08 SEK och antalet B-aktier till 34 485 918. Rådgivare Augment Partners AB är finansiell rådgivare och Hamilton Advokatbyrå KB är legal rådgivare till Oboya i samband med Företrädesemissionen. Aqurat Fondkommission AB agerar emissionsinstitut. För mer information, vänligen kontakta: Robert Wu, VD Oboya Horticulture Industries AB (publ) Tel: + 86 159 6983 5999 E-post: Hemsida: Erik Penser Bank AB är Oboyas Certified Advise

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 20206.12.2019 12:45:00 CETPress release

DUBLIN, Dec. 06, 2019 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 third quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2019. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 42 consecutive years. The dividend is payable on January 17, 2020, to shareholders of record at the close of business on December 27, 2019. About Medtronic Medtronic plc ( ), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 count

Oasmias företrädesemission övertecknad6.12.2019 12:25:00 CETPressemelding

Det preliminära utfallet i företrädesemissionen i Oasmia Pharmaceutical AB (publ) (”Oasmia” eller “Bolaget”), vars teckningsperiod avslutades den 4 december 2019, visar att 198 329 980 aktier tecknats i företrädesemissionen med stöd av teckningsrätter, vilket motsvarar cirka 99,5 procent av företrädesemissionen. Därutöver har Bolaget mottagit anmälningar om att teckna 78 277 041 aktier utan stöd av teckningsrätter, vilket motsvarar cirka 39,3 procent av företrädesemissionen. Företrädesemissionen är därmed övertecknad. ”Jag är mycket nöjd med utfallet i företrädesemissionen samt är tacksam för det stöd vi fått från våra aktieägare. Jag är imponerad av Oasmias ledningsgrupps prestationer, då de under press visat marknaden deras förmåga att utveckla Oasmia till en kommersiell organisation med en spännande framtida agenda”, kommenterar styrelseordförande Jörgen Olsson. Det preliminära utfallet i Oasmias företrädesemission, vars teckningsperiod löpte från och med den 20 november 2019 till o

Oasmia’s rights issue has been oversubscribed6.12.2019 12:25:00 CETPress release

The preliminary result of the rights issue in Oasmia Pharmaceutical AB (publ) (”Oasmia” or the “Company”), in which the subscription period ended on 4 December 2019, amounts to 198,329,980 shares subscribed for in the rights issue with subscription rights, which corresponds to approximately 99.5 percent of the rights issue. In addition, the Company has received applications to subscribe for 78,277,041 shares without subscription rights, corresponding to approximately 39.3 percent of the rights issue. Thus, the rights issue has been oversubscribed. “I am very pleased with the outcome in the rights issue, and grateful for the support from our shareholders. I’m impressed by the Oasmia team’s performance to, under pressure, show the market their determination to transform Oasmia into a commercial entity with a thrilling agenda going forward”, comments Jörgen Olsson, Chairman of the Board. The preliminary result of the rights issue in Oasmia, in which the subscription period took place from

Result of Riksbank reversed auctions SEK bonds6.12.2019 10:07:00 CETPress release

Auction date 2019-12-06 Loan 3109 Coupon 1.00 % ISIN-code SE0005703550 Maturity 2025-06-01 Tendered volume, SEK mln 250 +/- 250 Volume offered, SEK mln 750 Volume bought, SEK mln 250 Number of bids 5 Number of accepted bids 2 Average yield -1.917 % Lowest accepted yield -1.929 % Highest yield -1.899 % % accepted at lowest yield 60.00 Auction date 2019-12-06 Loan 3113 Coupon 0.125 % ISIN-code SE0009548704 Maturity 2027-12-01 Tendered volume, SEK mln 250 +/- 250 Volume offered, SEK mln 450 Volume bought, SEK mln 250 Number of bids 4 Number of accepted bids 1 Average yield -1.855 % Lowest accepted yield -1.855 % Highest yield -1.855 % % accepted at lowest yield 100.00


Almere, The Netherlands December 6, 2019 ASM International N.V. (Euronext Amsterdam: ASM) today announces that it will host a technical luncheon seminar in San Francisco, CA, US, on Wednesday, December 11, 2019, the third day of the IEDM Conference. At this technology seminar, ASM will highlight the challenges and potential solutions for metallization applications. The agenda is as follows: 11:30 am Reception, food and drinks 12:00 - 12:15 pm Welcome and introduction 12:15 - 1:00 pm Invited speaker: Dr. Raghuveer Makala (Western Digital) - "Metallization Challenges in 3D NAND Flash" Following the presentations, there is an opportunity for open discussion and networking until 1:15 pm. The ASM technology seminar will take place in the Golden Gate room (25th floor) at the Nikko Hotel (across from the Hilton San Francisco), San Francisco, CA 94102. The room will open at 11:30 am for invited attendees. Interested parties should contact Rosanne de Vries, +31 88 100 8569,